Cherry Creek Investment Advisors’s Sabra Healthcare REIT SBRA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$387K Buy
19,632
+113
+0.6% +$2.32K 0.15% 86
2026
Q2
$381K Buy
19,519
+113
+0.6% +$2.24K 0.15% 84
2026
Q1
$373K Buy
19,406
+106
+0.5% +$2.09K 0.16% 83
2025
Q4
$366K Buy
19,300
+113
+0.6% +$2.09K 0.16% 82
2025
Q3
$358K Buy
19,187
+113
+0.6% +$2.11K 0.15% 84
2025
Q2
$352K Buy
19,074
+802
+4% +$14.2K 0.16% 81
2025
Q1
$319K Buy
18,272
+3,099
+20% +$52.3K 0.17% 84
2024
Q4
$263K Buy
15,173
+434
+3% +$7.92K 0.13% 90
2024
Q3
$274K Buy
14,739
+257
+2% +$4.33K 0.14% 83
2024
Q2
$223K Buy
14,482
+235
+2% +$3.36K 0.12% 96
2024
Q1
$210K Buy
14,247
+3,767
+36% +$52.2K 0.11% 97
2023
Q4
$150K Buy
10,480
+322
+3% +$4.57K 0.09% 97
2023
Q3
$142K Buy
+10,158
New +$130K 0.1% 87

Other funds holding SBRA

Cherry Creek Investment Advisors's SBRA Position: Q3 2026 in Review

Cherry Creek Investment Advisors increased its Sabra Healthcare REIT (SBRA) stake by 0.58% in Q3 2026, buying an estimated $2.32K and bringing the position to 19,632 shares worth $387K. The position accounts for 0.15% of the portfolio, ranked #86.

Cherry Creek Investment Advisors first reported a position in SBRA in Q3 2023 and has held it in 13 quarters since. 47 funds tracked by Wall St. Rank hold SBRA as of Q3 2026.

  • Cherry Creek Investment Advisors held 19,632 shares of Sabra Healthcare REIT worth $387K as of Q3 2026.
  • Cherry Creek Investment Advisors bought 113 Sabra Healthcare REIT shares in Q3 2026, an estimated $2.32K.
  • Sabra Healthcare REIT made up 0.15% of Cherry Creek Investment Advisors's portfolio in Q3 2026, its #86 holding.
  • Cherry Creek Investment Advisors first reported a position in Sabra Healthcare REIT in Q3 2023 and has held it in 13 quarters since.
  • 47 funds tracked by Wall St. Rank held Sabra Healthcare REIT as of Q3 2026.

Based on Cherry Creek Investment Advisors's 13F filing for Q3 2026, filed 14 Oct 2026.